Burger, R. A., Deng, W., Makker, V., Collins, Y., Gray, H., Debernardo, R., . . . Aghajanian, C. (2018). Phase II Evaluation of Dalantercept in the Treatment of Persistent or Recurrent Epithelial Ovarian Cancer: An NRG Oncology/Gynecologic Oncology Group Study. Gynecol Oncol.
シカゴスタイル引用形Burger, Robert A., Wei Deng, Vicky Makker, Yvonne Collins, Heidi Gray, Robert Debernardo, Lainie P. Martin, , Carol Aghajanian. "Phase II Evaluation of Dalantercept in the Treatment of Persistent or Recurrent Epithelial Ovarian Cancer: An NRG Oncology/Gynecologic Oncology Group Study." Gynecol Oncol 2018.
MLA引用形式Burger, Robert A., et al. "Phase II Evaluation of Dalantercept in the Treatment of Persistent or Recurrent Epithelial Ovarian Cancer: An NRG Oncology/Gynecologic Oncology Group Study." Gynecol Oncol 2018.